![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/8372695-580268014-NovoNordisk-100x67.jpeg)
Citing manufacturing issue, FDA rejects Novo Nordisk's once-weekly insulin
In surging to the top spot in the market cap rankings in Europe, Novo Nordisk has been on an extended winning streak. But the FDA has slowed the roll for the Danish company, rejecting its once-a-week insulin icodec for patients with Type 1 and Type 2 …